Home Global Health Policy Topics

Global Health Policy

New and Noteworthy

The Trump Administration’s Latest Expansion of the Mexico City Policy: A Funding Analysis

On Friday, January 23, 2026, the Trump administration released the latest expansion of the Mexico City Policy (MCP). The controversial policy, which had restricted foreign non-governmental organizations (NGOs) from performing or promoting abortion as a method of family planning as a condition of receiving most U.S. global health aid, has been broadened significantly to include more organizations (not just foreign NGOs) and most U.S. foreign aid. Also, the policy now prohibits activities related to diversity, equity, and inclusion (DEI) as well as support for gender-affirming care and services, and legal protections based on gender identity (among other activities). This move marks the most significant expansion of the MCP in more than 40 years — extending its reach far beyond the policy’s expansion during Trump’s first term.

This analysis assesses the potential reach of the latest expansion of the Mexico City Policy, which is now part of the Promoting Human Flourishing in Foreign Assistance (PHFFA) Policy.

The Mexico City Policy: An Explainer

Questions for the America First Global Health Strategy

Global Health Budget Summaries

Overview of President Trump’s Executive Actions on Global Health

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials

Global Health Trackers

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Global Health Policy

Filter

List Grid

581 - 590 of 639 Results

  • The International Health Regulations and the U.S.: Implications of an Amended Agreement

    Issue Brief

    This brief reviews the proposed revisions to the World Health Organization-based agreement known as the International Health Regulations (IHR), and the implications for the U.S. WHO member states are expected to adopt the revised IHR at the World Health Assembly meeting this year. The U.S. government has been a leading proponent of many of the expected revisions to the IHR. In this analysis we also evaluate some of the criticisms of the revisions to the IHR.

  • Global Health Funding in the FY 2024 Final Appropriations Bill

    Fact Sheet

    Updated: March 25, 2024 On March 23, 2024, the President signed the second package of final FY 2024 appropriations bills, otherwise known as the “Further Consolidated Appropriations Act, 2024,” which was released by the House and Senate Appropriations Committees on March 20, 2024, passed by the House on March 22, 2024 and passed by the…

  • PEPFAR’s Short-Term Reauthorization Sets an Uncertain Course for Its Long-Term Future

    Policy Watch

    With the new omnibus bill, PEPFAR has been reauthorized until March 25, 2025, without the inclusion of any controversial provisions or changes related to abortion, sought by some. Still, while this latest step provides the program with some short-term certainty, including signaling bipartisan support (albeit limited), it marks a significant departure from PEPFAR’s past.

  • The Status of Funding for Zika: The President’s Request, Congressional Proposals, & Final Funding

    Issue Brief

    This issue brief provides a landscape of the status of U.S. funding for Zika, a mosquito-transmitted infection that in pregnant women can cause microcephaly as well as other serious birth defects. The brief compares the Congressionally approved Zika funding levels, which provides $1.1 billion to the Zika response, to the President’s February 22nd request, the House and Senate bills that passed each chamber in May, and a Conference Agreement that had been approved by the House in June, but was blocked in the Senate and opposed by the Administration.

  • COVID-19 Models: Can They Tell Us What We Want to Know?

    Policy Watch

    This blog gives a primer on epidemiological models for Covid-19 (coronavirus). It describes the uses and the types of models used, then lists a number of examples of different types of models and some key findings. The post also describes the limitations and assumptions related to these models, and how to use the information they provide more effectively.

  • The National Disaster Medical System (NDMS) and the COVID-19 Pandemic

    Issue Brief

    This explainer describes the National Disaster Medical System (NDMS), explores how it has been used in the past, and assesses how it is already being used or has been proposed to be used to fill gaps in the current response to the COVID-19 pandemic.